NWK Group’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-240
Closed -$44K – 165
2021
Q1
$44K Hold
240
– – 0.02% 110
2020
Q4
$48K Buy
+240
New +$48.8K 0.02% 109
2020
Q3
– Sell
-240
Closed -$46K – 250
2020
Q2
$46K Sell
240
-225
-48% -$39.4K 0.03% 101
2020
Q1
$72K Sell
465
-75
-14% -$8.72K 0.06% 69
2019
Q4
$45K Buy
+540
New +$41.1K 0.04% 104

Other funds holding TDOC

NWK Group's TDOC Position: Q2 2021 in Review

NWK Group sold out of Teladoc Health (TDOC) in Q2 2021, closing a stake of 240 shares — an estimated $44K sold.

NWK Group first reported a position in TDOC in Q4 2019 and held it in 5 quarters. The position peaked at $72K in Q1 2020. 829 funds tracked by Wall St. Rank hold TDOC as of Q2 2021.

  • NWK Group reported no remaining Teladoc Health position as of Q2 2021 after selling out during the quarter.
  • NWK Group sold 240 Teladoc Health shares in Q2 2021, an estimated $44K.
  • NWK Group first reported a position in Teladoc Health in Q4 2019 and held it in 5 quarters.
  • NWK Group's Teladoc Health position peaked at $72K in Q1 2020.
  • 829 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2021.

Based on NWK Group's 13F filing for Q2 2021, filed 16 Aug 2021.